Comparison between Testosterone Enanthate-Induced Azoospermia and Oligozoospermia in a Male Contraceptive Study. III. Higher 5α-Reductase Activity in Oligozoospermic Men Administered Supraphysiological Doses of Testosterone

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 3, 1996, Pages 902-908

  Anderson, R A ^a   Wallace, A M ^b   Wu, F C W ^c,d  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b GLASGOW ROYAL INFIRMARY   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ILEX COOKII;

ANDROSTANEDIOL; ANDROSTANOLONE; ANDROSTERONE; ETIOCHOLANOLONE; STEROID 5ALPHA REDUCTASE; TESTOSTERONE ENANTATE; TETRAHYDROCORTISOL;

ADULT; ARTICLE; AZOOSPERMIA; CLINICAL ARTICLE; CONTRACEPTION; ENZYME ACTIVITY; ENZYME ANALYSIS; HUMAN; MALE; OLIGOSPERMIA; PRIORITY JOURNAL; SEMEN ANALYSIS; SPERMATOGENESIS;

ANDROGENS; BIOLOGY; CLINICAL RESEARCH; CLINICAL TRIALS; COMPARATIVE STUDIES; CONTRACEPTION; CONTRACEPTION RESEARCH; CONTRACEPTIVE AGENTS; CONTRACEPTIVE AGENTS, MALE; DEVELOPED COUNTRIES; ENDOCRINE SYSTEM; ENZYMES; ENZYMES AND ENZYME INHIBITORS; EUROPE; FAMILY PLANNING; HORMONES; NORTHERN EUROPE; PHYSIOLOGY; RESEARCH METHODOLOGY; RESEARCH REPORT; SPERMATOGENESIS BLOCKING AGENTS; STUDIES; TESTOSTERONE; UNITED KINGDOM;

ADULT; ANDROSTANE-3,17-DIOL; CHOLESTENONE 5 ALPHA-REDUCTASE; CONTRACEPTIVE AGENTS, MALE; DIHYDROTESTOSTERONE; DOSE-RESPONSE RELATIONSHIP, DRUG; HORMONES; HUMANS; MALE; OLIGOSPERMIA; OXIDOREDUCTASES; TESTOSTERONE;

EID: 0029862979     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.81.3.8772548     Document Type: Review

References (66)

1. Wallace EM, Gow SM, Wu FCW. 1993 Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I. Plasma luteinizing hormone, follicle-stimulating hormone, testosterone, estradiol, and inhibin concentrations. J Clin Endocrinol Metab. 77:290-293.
2. Morse HC, Horike N, Rowley MJ, Heller CG. 1973 Testosterone concentrations in testes of normal men: effects of testosterone propionate administration. J Clin Endocrinol Metab. 37:882-888.
3. Swerdloff RS, Palacios A, McClure RD, Campfield LA, Brosman SA. 1978 Male contraception: clinical assessment of chronic administration of testosterone enanthate. Int J Androl. 2(Suppl):731-745.
4. Wu FCW, Aitken RJ. 1989 Suppression of sperm function by depot medroxyprogesterone acetate and testosterone enanthate in steroid male contraception. Fertil Steril. 51:691-697.
5. WHO Task Force for the Regulation of Male Fertility. 1990 Contraceptive efficacy of testosterone-induced azoospermia in normal men. Lancet. 336:955-959.
6. Pangkahila W. 1991 Reversible azoospermia induced by an androgen-progestin combination regimen in Indonesian men. Int J Androl. 14:248-256.
7. Lookingbill DP, Demers LM, Wang C, Leung A, Rittmaster RS, Santen RJ. 1991 Clinical and biochemical parameters of androgen action in normal healthy Caucasian versus Chinese subjects. J Clin Endocrinol Metab. 72:1242-1248.
8. Muir C, Waterhouse J, Mack T, Powell J, and Whelan S. 1987 Cancer incidence in five continents. Lyon: International Agency for Research on Cancer; vol 88.
9. Ross RK, Bernstein L, Lobo RA, et al. 1992 5-Alpha-reductase activity and the risk of prostatic cancer among Japanese and US white and black males. Lancet. 339:887-889.
10. Bruchovsky N, Wilson JD. 1968 The conversion of testosterone to 5α-androstan-17β-ol-3-one by rat prostate in vivo and in vitro. J Biol Chem. 243:2012-2021.
11. Walsh PC, Madden JD, Harrod MJ, Goldstein JL, Macdonald PC, Wilson JD. 1974 Familial incomplete male pseudohermaphroditism, type 2. Decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias. N Engl J Med. 291:944-949.
12. Dorfman RI, Shipley RA. 1956 Androgens: biochemistry, physiology and clinical significance. New York: Wiley.
13. Anderson KM, Liao S. 1968 Selective retention of dihydrotestosterone by prostatic nuclei. Nature. 219:277-279.
14. Grino PB, Griffin JE, Wilson JD. 1990 Testosterone at high concentrations interacts with the human androgen receptor similarly to dihydrotestosterone. J Clin Endocrinol Metab. 126:1165-1172.
15. Keenan BS, Meyer WJ, Hadjian AJ, Jones HW, Migeon CJ. 1974 Syndrome of androgen insensitivity in man: absence of 5α-dihydrotestosterone binding protein in skin fibroblasts. J Clin Endocrinol Metab. 38:1143-1146.
16. Kuttenn F, Mowszowicz I, Schaison G, Mauvais-Jarvis P. 1977 Androgen production and skin metabolism in hirsutism. J Endocrinol. 75:83-91.
17. Paulson RJ, Serafini PC, Catalino JA, Lobo RA. 1986 Measurements of 3α,17β-androstanediol glucuronide in serum and urine and the correlation with skin 5α-reductase activity. Fertil Steril. 46:222-226.
18. Imperato-McGinley J, Guerrero L, Gautier T, Peterson RE. 1974 Steroid 5α-reductase deficiency in man: an inherited form of male pseudohermaphroditism. Science. 186:1213-1215.
19. Peterson RE, Imperato-McGinley J, Gautier T, Sturla E. 1977 Male pseudohermaphroditism due to steroid 5α-reductase deficiency. Am J Med. 62:170-190.
20. Imperato-McGinley J, Peterson RE, Gautier T, Sturla E. 1979 Androgens and the evolution of male-gender identity among male pseudohermaphrodites with 5α-reductase deficiency. N Engl J Med. 22:1233-1237.
21. Johnson L, George FW, Neaves WB, et al. 1986 Characterization of the testicular abnormality in 5α-reductase deficiency. J Clin Endocrinol Metab. 63: 1091-1099.
22. Sharpe RM. 1990 Intratesticular control of steroidogenesis. Clin Endocrinol (Oxf). 33:787-807.
23. Ahmad N, Haltmeyer GC, Eik-Nes K. 1975 Maintenance of spermatogenesis with testosterone or dihydrotestosterone in hypophysectomized rats. J Endocrinol. 44:103-107.
24. Payne AH, Kawano A, Jaffe RB. 1973 Formation of dihydrotestosterone and other 5α-reduced metabolites by isolated seminiferous tubules and suspension of interstitial cells in a human testis. J Clin Endocrinol Metab. 37:448-453.
25. Rivarola MA, Podestá EJ, Chemes HE, Aguilar D. 1973 In vitro metabolism of testosterone by whole human testis, isolated seminiferous tubules and interstitial tissue. J Clin Endocrinol Metab. 37:454-460.
26. Rivarola MA, Podestá EJ, Chemes HE, Calandra RS. 1975 Androgen metabolism and concentration in the seminiferous tubules at different stages of development. J. Steroid Biochem. 6:365-369.
27. Nayfeh SN, Coffey JC, Hansson V, French FS. 1975 Maturational changes in testicular steroidogenesis: hormonal regulation of 5α-reductase. J Steroid Biochem. 6:329-335.
28. Thigpen AE, Silver RI, Guileyardo JM, Casey ML, McConnell JD, Russell DW. 1993 Tissue distribution and ontogeny of steroid 5α-reductase isoenzyme expression. J Clin Invest. 92:903-910.
29. WHO. 1987 WHO manual for the examination of human semen and semencervical mucus interaction, 2nd ed. Cambridge: Cambridge University Press.
30. Baird DT, Horton R, Longcope C, Tait JF. 1969 Steroid dynamics under steady-state conditions. Recent Prog Horm Res. 25:611-664.
31. Ito T, Horton R. 1971 The source of plasma dihydrotestosterone in man. J Clin Invest. 50:1621-1627.
32. Mowszowicz I, Bardin CW. 1977 Effect of androgens and progestins on mouse kidney cells: an in vitro model distinct from that of intact kidney. Mol Cell Endocrinol. 8:15-26.
33. Corker CS, Davidson DW. 1978 A radioimmunoassay for testosterone in various biological fluids without chromatography. J Steroid Biochem. 9:373-374.
34. 4-androstenedione to estrone in normal males and nonpregnant normal, castrate, and adrenlectomized females. J Clin Endocrinol Metab. 27:1103-1111.
35. Thompson DL, Rittmaster RS, Rodriguez AM, Moore Jr PH, Rao PN. 1991 Synthesis of new steroid haptens for radioimmunoassay. VIII. Development and validation of a specific radioimmunoassay for serum 5α-androstane-3α: 17β-diol 17-glucuronide. J Steroid Biochem. 36:345-349.
36. Bevan BR, Savvas M, Jenkins JM, Baker K, Pennington GW, Taylor NF. 1986 Abnormal steroid excretion in gestational trophoblastic disease complicated by ovarian theca-lutein cysts. J Clin Pathol. 39:627-634.
37. Anderson RA, Wu FCW. 1996 Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. II. Pharmacokinetics and pharmacodynamics of once-weekly administration of testosterone enanthate. J Clin Endocrinol Metab. 81:0000-0000
38. Giagulli VA, Verdonck L, Giorgino R, Vermeulen A. 1989 Precursors of plasma androstanediol- and androgen-glucuronides in women. J Steroid Biochem. 33:935-940.
39. Morimoto I, Edmiston A, Hawks D, Horton R. 1981 Studies on the origin of androstanediol and androstanediol glucuronide in young and elderly. J Clin Endocrinol Metab. 52:772-778.
40. Rittmaster RS, Zwicker H, Thomson DL, Konok G, Norman RW. 1993 Androstanediol glucuronide production in human liver, prostate, and skin. Evidence for the importance of the liver in 5α-reduced androgen metabolism. J Clin Endocrinol Metab. 76:977-982.
41. Giagulli VA, Verdonck L, Deslypere J-P, Giorgino R, Vermeulen A. 1993 Comparison of plasma androgen glucuronide levels after percutaneous or peroral androgen treatment in men: evidence for important splanchnic contribution to plasma 17β-hydroxyandrogen glucuronides. J Clin Endocrinol Metab. 76:429-431.
42. Horton R, Hawkes D, Lobo R. 1982 3α,17β Androstanediol glucuronide in plasma: a marker of androgen action in idiopathic hirsutism. J Clin Invest. 69:1203-1206.
43. Lobo RA, Goebelsmann U, Horton R. 1983 Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome. J Clin Endocrinol Metab. 57:393-397.
44. Lookingbill DP, Horton R, Demers LM, Egan N, Marks Jr JG, Santen RJ. 1985 Tissue production of androgens in women with acne. J Am Acad Dermatol. 12:481-487.
45. Lookingbill DP, Egan N, Santen RJ, Demers LM. 1988 Correlation of serum 3α-androstanediol glucuronide with acne and chest hair density in men. J Clin Endocrinol Metab. 67:986-991.
46. Scanlon MJ, Whorwood CB, Franks S, Reed MJ, James VHT. 1988 Serum androstanediol glucuronide concentrations in normal and hirsute women and patients with thyroid dysfunction. Clin Endocrinol (Oxf). 29:529-538.
47. Thompson DL, Horton N, Rittmaster RS. 1990 Androsterone glucuronide is a marker of adrenal hyperandrogenism in hirsute women. Clin Endocrinol (Oxf). 32:283-292.
48. Giagulli VA, Giorgino R, Vermeulen A. 1991 Is plasma 5α-androstane 3aα,17β-diol glucuronide a biochemical marker of hirsutism in women? J Steroid Biochem Mol Biol. 39:55-61.
49. Meikle AW, Odell WD. 1986 Effect of short- and long-term dexamethasone on 3α-androstanediol glucuronide in hirsute women. Fertil Steril. 46:277-231
50. Rittmaster RS, Thomson DL. 1990 Effect of leuprolide and dexamethasone on hair growth and hormone levels in hirsute women: the relative importance of the ovary and adrenal in the pathogenesis of hirsutism. J Clin Endocrinol Metab. 70:1096-1102.
51. Deslypere J-P, Sayed A, Punjabi U, Verdonck L, Vermeulen A. 1982 Plasma 5α-Androstane-3α,17β-diol and urinary 5α-androstane-3α,17β-diol glucuronide, parameters of peripheral androgen action: a comparative study. J Clin Endocrinol Metab. 54:386-391.
52. Rittmaster RS. 1993 Androgen conjugates: physiology and clinical significance. Endocr Rev. 14:121-132.
53. Giagulli VA, Giorgino R, Vermeulen A. 1993 Origin and significance plasma androsterone glucuronide levels: a parameter of adrenal androgen secretion and hepatic 5α-reductase activity. J Clin Endocrinol Metab. 76:91-923.
54. Bélanger A, Brochu M, Cliche J. 1986 Levels of plasma steroid glucuronide in intact and castrated men with prostatic cancer. J Clin Endocrinol Met 62:812-815.
55. Southren AL, Gordon GG, Tochimoto S, Pinzon G, Lane DR, Stypulkow W. 1967 Mean plasma concentration, metabolic clearance and blood production rates of testosterone in normal young men and women using a constant infusion proceedure: effect of the time of day and plasma concentration on the metabolic clearance rate of testosterone. J Clin Endocrinol Metab. 27:686-694.
56. Saez JM, Forest MG, Morera AM, Bertrand J. 1972 Metabolic clearance rate and blood production rate of testosterone and dihydrotestosterone in normal subjects, during pregnancy, and in hyperthyroidism. J Clin Invest. 51:1226-1235.
57. Imperato-McGinley J, Gautier T, Pichardo M, Shackleton C. 1986 The diagnosis of 5α-reductase deficiency in infancy. J Clin Endocrinol Metab. 63: 1313-1318.
58. Andersson S, Russell DW. 1990 Structural and biochemical properties of cloned and expressed human and rat steroid 5α-reductases. Proc Natl Acad Sci USA. 87:3640-3644.
59. Jenkins EP, Hseih C-L, Milatovich A, et al. 1991 Characterization and chromasomal mapping of a human steroid 5α-reductase gene and pseudogene and mapping of the mouse homologue. Genomics. 11:1102-1112.
60. Jenkins EP, Andersson S, Imperato-McGinley J, Wilson JD, Russell DW. 1992 Genetic and pharmacological evidence for more than one human steroid 5α-reductase. J Clin Invest. 89:293-300.
61. Mowszowicz I, Melanitou E, Doukani A, Wright F, Kuttenn F, Mauvais-Jarvis P. 1983 Androgen binding capacity and 5α-reductase activity in pubic skin fibroblasts from hirsute patients. J Clin Endocrinol Metab. 56:1209-1213.
62. George FW, Russell DW, Wilson JD. 1991 Feed-forward control of prostate growth: dihydrotestosterone induces expression of its own biosynthetic enzyme, steroid 5α-reductase. Proc Natl Acad Sci USA. 88:8044-8047.
63. Lephart ED, Simpson ER, Trzeciak WH. 1991 Rat adrenal 5α-reductase mRNA content and enzyme activity are sex hormone dependent. J Mol Endocrinol. 6:163-170.
64. Andersson S, Bishop RW, Russell DW. 1989 Expression cloning and regulation of steroid 5α-reductase, an enzyme essential for male sexual differentiation. J Biol Chem. 264:16249-16255.
65. Bardin CW, Swerdloff RS, Santen RJ. 1991 Androgens: risks and benefits. J Clin Endocrinol Metab. 73:4-7.
66. McConnell JD, Wilson JD, George FW, Geller J, Pappas F, Stoner E. 1992 Finasteride, an inhibitor of 5α-reductase, suppresses prostatic dihydrotestosterone in men with benign prostatic hyperplasia. J Clin Endocrinol Metab. 74:505-508.